rs736894

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_001360.3(DHCR7):​c.626+15G>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.242 in 1,613,024 control chromosomes in the GnomAD database, including 55,153 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.31 ( 7983 hom., cov: 33)
Exomes 𝑓: 0.24 ( 47170 hom. )

Consequence

DHCR7
NM_001360.3 intron

Scores

3

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:13

Conservation

PhyloP100: -0.534

Publications

14 publications found
Variant links:
Genes affected
DHCR7 (HGNC:2860): (7-dehydrocholesterol reductase) This gene encodes an enzyme that removes the C(7-8) double bond in the B ring of sterols and catalyzes the conversion of 7-dehydrocholesterol to cholesterol. This gene is ubiquitously expressed and its transmembrane protein localizes to the endoplasmic reticulum membrane and nuclear outer membrane. Mutations in this gene cause Smith-Lemli-Opitz syndrome (SLOS); a syndrome that is metabolically characterized by reduced serum cholesterol levels and elevated serum 7-dehydrocholesterol levels and phenotypically characterized by cognitive disability, facial dysmorphism, syndactyly of second and third toes, and holoprosencephaly in severe cases to minimal physical abnormalities and near-normal intelligence in mild cases. Alternative splicing results in multiple transcript variants that encode the same protein.[provided by RefSeq, Aug 2009]
DHCR7 Gene-Disease associations (from GenCC):
  • Smith-Lemli-Opitz syndrome
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, Laboratory for Molecular Medicine, Labcorp Genetics (formerly Invitae), G2P, ClinGen, Myriad Women's Health

Genome browser will be placed here

new If you want to explore the variant's impact on the transcript NM_001360.3, check out the Mutation Effect Viewer. This is especially useful for frameshift variants or if you want to visualize the effect of exon loss / intron retention.

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.82).
BP6
Variant 11-71441212-C-T is Benign according to our data. Variant chr11-71441212-C-T is described in ClinVar as Benign. ClinVar VariationId is 93721.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.455 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_001360.3. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
DHCR7
NM_001360.3
MANE Select
c.626+15G>A
intron
N/ANP_001351.2A0A024R5F7
DHCR7
NM_001425107.1
c.626+15G>A
intron
N/ANP_001412036.1A0A804HI25
DHCR7
NM_001425108.1
c.662+15G>A
intron
N/ANP_001412037.1A0A804HJQ7

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
DHCR7
ENST00000355527.8
TSL:1 MANE Select
c.626+15G>A
intron
N/AENSP00000347717.4Q9UBM7
DHCR7
ENST00000407721.6
TSL:1
c.626+15G>A
intron
N/AENSP00000384739.2Q9UBM7
DHCR7
ENST00000685320.1
c.41+15G>A
intron
N/AENSP00000509319.1B4E1K5

Frequencies

GnomAD3 genomes
AF:
0.309
AC:
46943
AN:
151958
Hom.:
7980
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.421
Gnomad AMI
AF:
0.326
Gnomad AMR
AF:
0.285
Gnomad ASJ
AF:
0.219
Gnomad EAS
AF:
0.411
Gnomad SAS
AF:
0.473
Gnomad FIN
AF:
0.376
Gnomad MID
AF:
0.363
Gnomad NFE
AF:
0.220
Gnomad OTH
AF:
0.334
GnomAD2 exomes
AF:
0.298
AC:
74170
AN:
249116
AF XY:
0.304
show subpopulations
Gnomad AFR exome
AF:
0.427
Gnomad AMR exome
AF:
0.208
Gnomad ASJ exome
AF:
0.223
Gnomad EAS exome
AF:
0.411
Gnomad FIN exome
AF:
0.366
Gnomad NFE exome
AF:
0.235
Gnomad OTH exome
AF:
0.281
GnomAD4 exome
AF:
0.236
AC:
344101
AN:
1460948
Hom.:
47170
Cov.:
32
AF XY:
0.243
AC XY:
176757
AN XY:
726836
show subpopulations
African (AFR)
AF:
0.440
AC:
14718
AN:
33456
American (AMR)
AF:
0.215
AC:
9614
AN:
44716
Ashkenazi Jewish (ASJ)
AF:
0.220
AC:
5762
AN:
26134
East Asian (EAS)
AF:
0.464
AC:
18404
AN:
39694
South Asian (SAS)
AF:
0.471
AC:
40596
AN:
86228
European-Finnish (FIN)
AF:
0.358
AC:
19110
AN:
53384
Middle Eastern (MID)
AF:
0.333
AC:
1917
AN:
5758
European-Non Finnish (NFE)
AF:
0.196
AC:
218336
AN:
1111218
Other (OTH)
AF:
0.259
AC:
15644
AN:
60360
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.493
Heterozygous variant carriers
0
13067
26134
39200
52267
65334
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
7582
15164
22746
30328
37910
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.309
AC:
46952
AN:
152076
Hom.:
7983
Cov.:
33
AF XY:
0.320
AC XY:
23794
AN XY:
74356
show subpopulations
African (AFR)
AF:
0.420
AC:
17417
AN:
41452
American (AMR)
AF:
0.284
AC:
4347
AN:
15288
Ashkenazi Jewish (ASJ)
AF:
0.219
AC:
761
AN:
3472
East Asian (EAS)
AF:
0.412
AC:
2125
AN:
5158
South Asian (SAS)
AF:
0.471
AC:
2271
AN:
4824
European-Finnish (FIN)
AF:
0.376
AC:
3982
AN:
10582
Middle Eastern (MID)
AF:
0.342
AC:
100
AN:
292
European-Non Finnish (NFE)
AF:
0.220
AC:
14940
AN:
67988
Other (OTH)
AF:
0.337
AC:
712
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
1646
3292
4939
6585
8231
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
460
920
1380
1840
2300
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.274
Hom.:
1793
Bravo
AF:
0.299
Asia WGS
AF:
0.395
AC:
1370
AN:
3478

ClinVar

ClinVar submissions
Significance:Benign
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
6
not specified (6)
-
-
5
Smith-Lemli-Opitz syndrome (5)
-
-
2
not provided (2)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.82
CADD
Benign
1.7
DANN
Benign
0.83
PhyloP100
-0.53
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.

Publications

Other links and lift over

dbSNP: rs736894;
hg19: chr11-71152258;
COSMIC: COSV62796127;
COSMIC: COSV62796127;
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.